Local News Takeda and Carmine Enter $900 Million Non-Viral Gene Therapy Collaboration BioSpace | July 2, 2020 Cambridge, Massachusetts-based Carmine Therapeutics inked a research collaboration deal with Japan’s Takeda Pharmaceutical to develop and commercialize non-viral gene…eabramovichJuly 2, 2020 Read More
Local News A Focused Approach to Imaging Neural Activity in the Brain MIT News | July 1, 2020 When neurons fire an electrical impulse, they also experience a surge of calcium ions. By…eabramovichJuly 1, 2020 Read More
Local News Acid Test Harvard Medical School | July 1, 2020 Researchers at Harvard Medical School and the Harvard Stem Cell Institute studying embryonic development have…eabramovichJuly 1, 2020 Read More
Local News These Muscle Cells Are Guideposts to Help Regenerative Flatworms Grow Back Their Eyes Whitehead Institute | June 30, 2020 If anything happens to the eyes of the tiny, freshwater-dwelling planarian Schmidtea mediterranea, they can grow them…eabramovichJune 30, 2020 Read More
Local News “Genetic Trades” of More than 50 Gene Variants Are Linked to Common Blood Disorder Broad Institute | June 30, 2020 Researchers at the Broad Institute of MIT and Harvard, Harvard Medical School, and Brigham and…eabramovichJune 30, 2020 Read More
Local News A Fish Called Spondo Harvard Medical School | June 30, 2020 A spine is a spine is a spine—or is it? From sharks to salamanders to…eabramovichJune 30, 2020 Read More
Local News Different “Subtypes” of Alzheimer’s May be Linked to Different Modifications of the Tau Protein, Mass General-Led Team Finds Massachusetts General Hospital | June 29, 2020 A new study reveals a possible biological reason that Alzheimer’s Disease (AD) progresses at different rates in…eabramovichJune 29, 2020 Read More
Local News Brain Targeting Program: Shuttles for Brain Delivery of Therapeutics and Diagnostics Wyss Institute | June 29, 2020 In its Brain Targeting Program, a Wyss team led by Founding Director Donald Ingber, M.D., Ph.D.…eabramovichJune 29, 2020 Read More
Local News Yumanity and Merck Ink $500 Million+ Deal for Neurodegenerative Diseases BioSpace | June 26, 2020 Yumanity Therapeutics and Merck signed a strategic research and license deal for two Yumanity programs. The two preclinical programs…eabramovichJune 26, 2020 Read More
Local News Experimental Peptide Targets COVID-19 MIT News | June 26, 2020 Using computational models of protein interactions, researchers at the MIT Media Lab and Center for…eabramovichJune 26, 2020 Read More